Effect of therapy reminder application on therapy-adherence
- Conditions
- Major Thalassaemia.Beta thalassemiaD56.1
- Registration Number
- IRCT20240222061079N1
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 80
1- Patients with thalassemia major aged 18 years and older who have an active file in Sarwar Clinic and are being treated with blood transfusion and iron removal drugs
2- Having an active smartphone that works with the Android operating system,
3- They have sufficient skills in Farsi or English to work with a smartphone and the ability to use it
4- They do not have mental illness and hearing and vision problems (due to hearing and seeing application alarms)
5- Provide written informed consent to participate in the research.
1- Patients were excluded if they themselves used a medication reminder app or other electronic reminder systems to adhere to their medication regimen, for example calendar alerts on their phones.
2- Patients with smartphones that are unable to download apps are excluded.
3- If a person reports not using the reminder program in two phone calls by the researcher, he will be excluded from the study.
4- Patients who do not want to continue cooperation for any reason will be excluded from the study during the study period.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Adherence to treatment. Timepoint: Before and after the intervention (8 weeks apart). Method of measurement: Moriski questionnaire and chronic patient treatment adherence questionnaire.
- Secondary Outcome Measures
Name Time Method Evaluation of the designed application. Timepoint: Once designed. Method of measurement: Application evaluation questionnaire.